Page 39 - AIH-2-4
P. 39

Artificial Intelligence in Health





                                        ORIGINAL RESEARCH ARTICLE
                                        Deep vision transformers in neurodegenerative

                                        disease diagnosis using  F-fluorodeoxyglucose
                                                                          18
                                        positron emission tomography scans and

                                        anatomical brain atlas



                                        Pooriya Khorramyar* , Amira Soliman , Farzaneh Etminani , and Stefan Byttner
                                        Center for Applied Intelligent Systems Research in Health (CAISR Health), The School of Information
                                        Technology, Halmstad University, Halmstad, Halland, Sweden
                                        (This article belongs to the Special Issue: Artificial intelligence for diagnosing brain diseases)



                                        Abstract

                                        This research explores adapting vision transformers (ViTs) to classify
                                        neurodegenerative diseases while ensuring their decision-making process is
                                        interpretable. We developed a model to classify  F-fluorodeoxyglucose ( F-FDG)
                                                                                  18
                                                                                                      18
                                        positron emission tomography (PET) brain scans into three categories: cognitively
                                        normal (CN), mild cognitive impairment (MCI), and Alzheimer’s disease (AD). The
            *Corresponding author:
                                                                                      18
            Pooriya Khorramyar          dataset utilized in this research contains 580 samples of  F-FDG PET scans obtained
            (pookho20@student.hh.se)    from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). The proposed model
            Citation: Khorramyar P, Soliman A,   obtained an F1 score of 81% (macro-average of all classes) on the test dataset, a
            Etminani F, Byttner S. Deep vision   significant performance improvement compared to the literature. Furthermore,
            transformers in neurodegenerative   we combined the model’s attention maps with the Automated Anatomical Atlas 3
            disease diagnosis using
            18F-fluorodeoxyglucose positron   (AAL3), which represents a digital brain map, to identify the most influential areas on
            emission tomography scans and   the model’s predictions and to conduct a regions’ importance study as a step toward
            anatomical brain atlas. Artif Intell   explainability. We demonstrated that ViTs can achieve competitive performance
            Health. 2025;2(4):33-46.
            doi: 10.36922/AIH025140026  compared  to  convolutional  neural  networks  while  enabling  the  development  of
                                        explainable models without extra computations due to the attention mechanism.
            Received: March 31, 2025
            1st revised: April 12, 2025
                                        Keywords: Vision transformer; Neurodegenerative disease;  F-FDG PET; Medical image
                                                                                      18
            2nd revised: May 22, 2025   analysis; Brain scan; Deep neural network
            Accepted: May 26, 2025
            Published online: June 19, 2025
            Copyright: © 2025 Author(s).   1. Introduction
            This is an Open-Access article
            distributed under the terms of the   Neurodegenerative diseases (NDDs) lead to progressive deterioration and death
            Creative Commons Attribution   of neurons, damaging the nervous system and brain. Affecting more than 55
            License, permitting distribution, and
            reproduction in any medium, which   million patients with a yearly increase rate of 10 million new cases worldwide,
            provided that the original work is   NDDs are a prominent cause of disability and death.  In addition, Alzheimer’s
                                                                                       1
            properly cited.             disease (AD), as the most widespread form, accounts for 70% of NDD cases and
                                                                            1
            Publisher’s Note: AccScience   plays a significant role in these statistics.  Although NDDs have a heavy impact
            Publishing remains neutral with   on healthcare systems and patients’  lives,  they  remain incurable  as of  today.
                                                                                                             1
            regard to jurisdictional claims in
            published maps and institutional   However, timely diagnosis is pivotal in disease management and improving the
            affiliations.               patient’s quality of life. 2


            Volume 2 Issue 4 (2025)                         33                          doi: 10.36922/AIH025140026
   34   35   36   37   38   39   40   41   42   43   44